These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3813570)

  • 1. [Ministry of Education Group on Special Comprehensive Cancer Study: Report by the special committee on antineoplastic agent screening].
    Gan To Kagaku Ryoho; 1987 Jan; 14(1 Pt 2):227-361. PubMed ID: 3813570
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of random screening of possible antineoplastic agents in Japan using mouse cancer. 3].
    Gan To Kagaku Ryoho; 1984 Sep; 11(9 Pt 2):1899-2096. PubMed ID: 6497404
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.
    Marsh JC; Shoemaker RH; Suffness M
    Cancer Treat Rep; 1985 Jun; 69(6):683-5. PubMed ID: 4016772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
    Gutsche W; Schulze W; Jungstand W; Wohlrabe K
    Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening study on Taiwan plants for antitumor activities.
    King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ
    Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546
    [No Abstract]   [Full Text] [Related]  

  • 9. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
    Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of antitumor screening relative to activity criteria.
    Paull K; Hodes L; Simon RM
    J Natl Cancer Inst; 1986 Jun; 76(6):1137-42. PubMed ID: 3458950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible modality for overcoming drug resistance].
    Tsuruo T
    Rinsho Ketsueki; 1985 Jun; 26(6):877-9. PubMed ID: 4068249
    [No Abstract]   [Full Text] [Related]  

  • 14. Pleiotropic resistance and drug development.
    Shoemaker R; Wolpert-DeFilippes M; Plowman J; Abbott B; Venditti J; Trader M; Griswold D; Gerlach J; Ling V
    Prog Clin Biol Res; 1986; 223():143-9. PubMed ID: 3809196
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and utilization of inbred strains of mice for cancer research.
    Heston WE
    Prog Clin Biol Res; 1981; 45():279-90. PubMed ID: 7243819
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychotropic drugs and new 1,5-benzodiazepine analogs as antitumor agents].
    Werner W; Wohlrabe K; Gutsche W; Jungstand W; Römer W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):637-42. PubMed ID: 6172326
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance studies on intraspecific hybridomas.
    Pályi I; Turi G; Szikla K; Dallmann L
    Arch Geschwulstforsch; 1981; 51(1):119-24. PubMed ID: 7259434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
    Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
    Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problem of screening of antineoplastic drugs in tissue and cell cultures].
    Dobrynin IaV
    Eksp Onkol; 1985; 7(2):9-15. PubMed ID: 4006851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro and in vivo investigation of three surface-active agents as modulators of cell proliferation.
    Tobler J; Watts MT; Fu JJ
    Cancer Res; 1980 Apr; 40(4):1173-80. PubMed ID: 7357547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.